Ligand Pharms Cvr Stock Today
Ligand Pharms is trading at 0.0032 as of the 25th of April 2024; that is 6.67 percent increase since the beginning of the trading day. The stock's open price was 0.003. Equity ratings for Ligand Pharms Cvr are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Valuation
Check how we calculate scores
Ligand Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ligand Pharms' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ligand Pharms or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Other, Other (View all Sectors) |
Ligand Pharms Cvr [LGNDZ] is a Pink Sheet which is traded between brokers as part of OTC trading. The company classifies itself under Other sector and is part of Other industry. Ligand Pharms Cvr has 0 outstanding shares.
Ligand Pharms generates positive cash flow from operations, but has no cash available
Check Ligand Pharms Probability Of Bankruptcy
Ligand Pharms Cvr Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Ligand Pharms market risk premium is the additional return an investor will receive from holding Ligand Pharms long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Ligand Pharms. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Ligand Pharms' alpha and beta are two of the key measurements used to evaluate Ligand Pharms' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 38.13 | |||
| Semi Deviation | 28.29 | |||
| Standard Deviation | 63.14 | |||
| Variance | 3986.74 |
Ligand Stock Against Markets
Picking the right benchmark for Ligand Pharms pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Ligand Pharms pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Ligand Pharms is critical whether you are bullish or bearish towards Ligand Pharms Cvr at a given time. Please also check how Ligand Pharms' historical prices are related to one of the top price index indicators.
Ligand Pharms Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ligand Pharms pink sheet to make a market-neutral strategy. Peer analysis of Ligand Pharms could also be used in its relative valuation, which is a method of valuing Ligand Pharms by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
How to buy Ligand Pink Sheet?
Before investing in Ligand Pharms, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Ligand Pharms. To buy Ligand Pharms stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Ligand Pharms. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Ligand Pharms stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Ligand Pharms Cvr stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Ligand Pharms Cvr stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Ligand Pharms Cvr, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Ligand Pharms Cvr?
The danger of trading Ligand Pharms Cvr is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ligand Pharms is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ligand Pharms. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ligand Pharms Cvr is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Ligand Pharms Cvr information on this page should be used as a complementary analysis to other Ligand Pharms' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Ligand Pink Sheet analysis
When running Ligand Pharms' price analysis, check to measure Ligand Pharms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ligand Pharms is operating at the current time. Most of Ligand Pharms' value examination focuses on studying past and present price action to predict the probability of Ligand Pharms' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ligand Pharms' price. Additionally, you may evaluate how the addition of Ligand Pharms to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world |